(NASDAQ: WVE) Wave Life Sciences's forecast annual revenue growth rate of 54.95% is forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 37.38%, and it is also forecast to beat the US market's average forecast revenue growth rate of 14.35%.
Wave Life Sciences's revenue in 2026 is $42,727,000.On average, 17 Wall Street analysts forecast WVE's revenue for 2026 to be $7,909,531,892, with the lowest WVE revenue forecast at $0, and the highest WVE revenue forecast at $15,615,748,434. On average, 17 Wall Street analysts forecast WVE's revenue for 2027 to be $14,685,392,452, with the lowest WVE revenue forecast at $1,871,630,753, and the highest WVE revenue forecast at $32,084,291,810.
In 2028, WVE is forecast to generate $31,976,986,486 in revenue, with the lowest revenue forecast at $2,836,437,392 and the highest revenue forecast at $78,869,412,978.